BETHESDA, Md., Feb. 24, 2011 /PRNewswire/ -- BrainScope Company, Inc. today announced that Peter JD Andrews M.D., MB.Ch.B., FRCA has joined its Medical Advisory Board. He holds the distinguished title of Professor of Anaesthetics & Critical Care at the University of Edinburgh, Scotland, United Kingdom. This appointment coincides with BrainScope's recent announcement that it is entering the U.K. market with its "B-Ahead U.K. Trial", a multi-center, observational clinical study utilizing its technology in development to aid in the assessment of traumatic brain injury (TBI) and its milder forms (commonly referred to as "concussion") in emergency departments in the U.K.
"Professor Andrews is one of the most preeminent traumatic brain injury thought leaders in the world today," said BrainScope Chief Executive Officer Michael Singer. "His extensive background and combined focus on brain injury and critical care make him a perfect addition to our Medical Advisory Board. We are honored that he has joined us and look forward to learning from him, particularly with our continuing focus on the United Kingdom."
In addition to his professorship at the University of Edinburgh, Professor Andrews is currently Consultant in Anaesthesia and Intensive Care at Western General Hospital in Edinburgh, Scotland. He is a member of the European Society of Intensive Care Medicine, and previously elected section Chairman of Neurological Intensive Care on two occasions and a member of the Medical Research Council (UK) College of Experts. He is currently involved in several research grants, including the Eurotherm3235Trial, an international, multi-center, randomized controlled trial that examines the effects of hypothermia as a treatment for severe traumatic brain injury, where he serves as chief investigator. Professor Andrews is editor in chief for The Open Critical Care Medicine Journal and has been associate editor